Biotech Investors & VC Firms
2475 firms in this list, with a median first check of $500K. 505 of them lead rounds. Generated from verified public data and updated continuously.
UNSW
SydneyPre-Seed–Series A
Ausvic Capital
Hong KongPre-Seed–Series A
Egora Holding
MartinsriedSeed–Series B$5.4M
Fshd Global Research Foundation
Sydney SouthSeed
GERBER-RAUTH
MilanPre-Seed–Late Stage
Mankind Pharma
New DelhiSeries A
Union Investment Partners
SeoulSeed–Series A
VentureTECH
SelangorSeries A
Yuuwa Capital
PerthSeed–Series A
CIBC
TorontoPre-Seed–Late Stage$1.5M – $29.2M
1 person
NYA Ventures
CalgaryPre-Seed–Series A
1 person
Action Potential Venture Capital Ltd.
Scotts ValleySeed–Late Stage
3 people
Allele Capital Partners
Fort Lauderdale
6 people
Cryptology Asset Group
Sliema
Desire Ventures LLC
Seed–Series A
Estari Group
LondonLate Stage
IMM Investment
KangnamPre-Seed–Growth
KB Financial Group
Seoul
Kite Entrepreneurship Foundation
DaejeonPre-Seed–Seed
KU Leuven Research & Development
Pre-Seed
Onex Corporation
TorontoGrowth–Late Stage
Ontario Center of Excellence
TorontoPre-Seed–Seed
Qatar Foundation
DohaPre-Seed
RMGP Biopharma Investment Fund
HerzliyaSeed–Series A
6 people
Related lists
Investors & VC Firms in North America (12835)Investors & VC Firms in United States (11883)Investors & VC Firms in Europe (5830)Investors & VC Firms in Global (4736)AI & Machine Learning Investors & VC Firms (4564)Fintech Investors & VC Firms (4546)SaaS Investors & VC Firms (4222)Healthtech Investors & VC Firms (4190)Enterprise Software Investors & VC Firms (4099)Crypto & Web3 Investors & VC Firms (3974)
Data sourced from public filings and firms' own websites — see our methodology.










